Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 8 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,384.3347 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 7 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,682.3347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 12 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · derivative · entry 14 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Bio-Rad A Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,575 | $478.32 | $753,354.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,819 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 5 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 82 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · derivative · entry 11 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82 Underlying: Bio-Rad A Common Stock · 82 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 34 | $478.32 | $16,262.88 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 6 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 82 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 5 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · derivative · entry 11 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 285 | $478.32 | $136,321.20 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 6 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,248.2754 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 5 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,533.2754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · derivative · entry 11 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 248 | $478.32 | $118,623.36 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 6 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153.2125 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 5 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,401.2125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · derivative · entry 11 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 6 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,082.3347 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 5 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,380.3347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 11 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 6 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,238 Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 5 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,319 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · derivative · entry 13 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,640 Underlying: Bio-Rad A Common Stock · 2,319 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,405 | $478.32 | $672,039.60 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 4 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,794 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 56 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · derivative · entry 10 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112 Underlying: Bio-Rad A Common Stock · 56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 23 | $478.32 | $11,001.36 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 526 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · derivative · entry 10 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052 Underlying: Bio-Rad A Common Stock · 526 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 182 | $478.32 | $87,054.24 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 4 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933.2754 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 3 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115.2754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 464 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · derivative · entry 10 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 928 Underlying: Bio-Rad A Common Stock · 464 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 161 | $478.32 | $77,009.52 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 4 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,901.2125 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 3 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,062.2125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · derivative · entry 10 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 188 | $478.32 | $89,924.16 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 4 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,780.3347 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · nonDerivative · entry 3 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,968.3347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · derivative · entry 10 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 241 | $478.32 | $115,275.12 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 4 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,936 Read SEC document |
| September 03, 2022 Filed Sep 7, 2022 18:07 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019276 · form4.xml · nonDerivative · entry 3 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 1,805 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · derivative · entry 12 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,610 Underlying: Bio-Rad A Common Stock · 1,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,094 | $478.32 | $523,282.08 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,880 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 1,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:27 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019292 · form4.xml · derivative · entry 3 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Bio-Rad A Common Stock · 433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:27 UTC |
WRIGHT DARAExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 150 | $478.32 | $71,748.00 |
DisclosureSEC source: 0001062993-22-019292 · form4.xml · nonDerivative · entry 2 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459.8996 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:27 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019292 · form4.xml · nonDerivative · entry 1 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609.8996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 43 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · derivative · entry 9 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88 Underlying: Bio-Rad A Common Stock · 43 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 18 | $478.32 | $8,609.76 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.